TGFB1 and breast carcinoma: In tumors with an intact TGFβR1/2-SMAD2/3 pathway, including most SCCs, glioblastomas, and breast cancers, the activation of oncogenes synergizes with TGFβ signaling to induce EMT rather than TGI.